Key Sessions
Bahija Jallal
Advances in Bispecific, Soluble TCR Therapies
Immunocore
June 10 - Live Sessionskeyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
June 10 - Live Sessions - BST (British Summer Time, GMT+1)
keyboard_arrow_leftSearch & Filter
search
Streams
Formats
June 10 - Live Sessions - BST (British Summer Time, GMT+1)
search
Streams
Formats
June 10 - Live Sessions 09:45 - 10:1530 mins
Scientific Briefing
June 10 - Live Sessions 10:30 - 11:0030 mins
Scientific Briefing
June 10 - Live Sessions 11:15 - 12:1560 mins
Keynote Presentation with Introduction by Session Chair
Advances in Bispecific, Soluble TCR Therapies
- Bahija Jallal - Chief Executive Officer, Immunocore
To prepare for this discussion/Q&A, attendees should watch the On-Demand presentations from speakers in this session in advance. These on-demand talks will be available for viewing starting June 1.
June 10 - Live Sessions 12:30 - 13:1545 mins
Live Panel Discussion & Speaker Q&A
New Approaches to Multispecific Antibody Treatment
- Paul Parren, PhD - EVP, Head of R&D and Professor, Lava Therapeutics and Leiden University
- Aran Labrijn, PhD - Principal Scientist, Antibody Research and Technology, Genmab
- Dimitris Skokos , Ph.D. - Senior Director, Cancer Immunology, Regeneron Pharmaceuticals
- Paul Moore, Ph.D. - Vice President, Immunology & Cell Biology, MacroGenics
- Marcel Walser, Ph.D. - Senior Director Research, Molecular Partners
- Chan Cao, Ph.D. - Chief Executive Officer, Assembly Medicine LLC
- Nizar El-Murr, Ph.D. - Principal Scientist - Immuno-Oncology Research, Sanofi
June 10 - Live Sessions 14:15 - 14:4530 mins
Scientific Briefing
June 10 - Live Sessions 15:00 - 15:3030 mins
Scientific Briefing
Scientific Briefing
To prepare for this discussion/Q&A, attendees should watch the On-Demand presentations from speakers in this session in advance. These on-demand talks will be available for viewing starting
June 10 - Live Sessions 15:45 - 16:3045 mins
Live Panel Discussion & Speaker Q&A
Exploiting and Understanding Avidity Engineering of Antibodies
- Greg Lazar, Ph.D. - Director and Senior Scientist, Antibody Engineering, Genentech
- Daniel Lingwood - Assistant Professor of Medicine, The Ragon Institute of MGH, MIT and Harv
- Harald Wajant, Ph.D. - Professor, Department of Internal Medicine II, University Hospital Würzburg
- Nicholas Agard, Ph.D. - Senior Scientist, Antibody Engineering, Genentech
- Simone Oostindie - Scientist, Early Stage Translational Research, Genmab
- Friedrich Koch-Nolte, PhD - Professor of Immunology and Molecular Biology, University Medical Center Hamburg-Eppend
Get the latest news.
As it happens
Sign up to get the latest on the agenda and speakers.
Filter
Streams
Formats
Choose Day
- Pre-Conf Training Course - Intro to Antibody Engineering - June 1-3Pre-Conf Training Course - Intro to Antibody Engineering - June 1-3
- June 8 - Live SessionsJune 8 - Live Sessions
- June 9 - Live SessionsJune 9 - Live Sessions
- June 10 - Live SessionsJune 10 - Live Sessions
- Post-Conf Training Course - Intro to Bioconjugates & ADCs - June 15-17Post-Conf Training Course - Intro to Bioconjugates & ADCs - June 15-17
- ON-DEMAND, Pre-Recorded Speaker PresentationsON-DEMAND, Pre-Recorded Speaker Presentations
- Download Agenda